Positive fecal immunochemical test results are associated with non-colorectal cancer mortality

被引:11
|
作者
Jung, Yoon Suk [1 ]
Lee, Jinhee [2 ]
Moon, Chang Mo [3 ,4 ]
机构
[1] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Internal Med, Div Gastroenterol,Sch Med, Seoul, South Korea
[2] Ajou Univ, Dept Endocrinol & Metab, Sch Med, Suwon, South Korea
[3] Ewha Womans Univ, Dept Internal Med, Sch Med, 1071 Anyangcheon Ro, Seoul 07985, South Korea
[4] Ewha Womans Univ, Inflammat Canc Microenvironm Res Ctr, Seoul, South Korea
来源
KOREAN JOURNAL OF INTERNAL MEDICINE | 2022年 / 37卷 / 02期
关键词
Fecal immunochemical test; Mortality; Colorectal neoplasms; SOCIETY TASK-FORCE; RISK-FACTORS; BLOOD; NEOPLASIA; RECOMMENDATIONS; INFLAMMATION; MICROBIOTA; TRIAL;
D O I
10.3904/kjim.2021.081
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Aims: Studies have reported an association between fecal occult blood and increased all-cause, non-colorectal cancer (CRC) as well as CRC mortality. This study aimed to determine whether positive fecal immunochemistry test (FIT) results are associ-ated with death from various causes in the South Korean population. Methods: Using the Korean National Cancer Screening Program database, we collected data on patients who underwent FIT between 2009 and 2011. Results: Of the 5,932,544 participants, 380,789 (6.4%) had positive FIT results. FIT -posi-tive participants had a higher mortality rate than FIT-negative participants from CRC (1.33 and 0.21 per 1,000 person-years, p < 0.001, respectively) and non-CRC causes (10.40 and 7.50 per 1,000 person-years, p < 0.001, respectively). Despite adjusting for age, sex, smoking status, alcohol consumption habits, body mass index, comorbidity, and aspirin use, FIT positivity was associated with an increased risk of dying from all non-CRC causes (adjusted hazard ratio [aHR], 1.17; 95% confidence interval [CI], 1.15 to 1.18) and CRC (aHR, 5.61; 95% CI, 5.40 to 5.84). Additionally, FIT positivity was significantly associated with increased mortality from circulatory disease (aHR, 1.14; 95% CI, 1.11 to 1.17), respi-ratory disease (aHR, 1.14; 95% CI, 1.09 to 1.19), digestive disease (aHR, 1.57; 95% CI, 1.48 to 1.66), neuropsychological disease (aHR, 1.08; 95% CI, 1.01 to 1.16), blood and endo-crine diseases (aHR, 1.10; 95% CI, 1.04 to 1.17), and external factors (aHR, 1.16; 95% CI, 1.11 to 1.20). Conclusions: Positive FIT results are associated with an increased risk of mortality from CRC and various other chronic diseases, suggesting that it could be a predictor of mortal-ity independent of its association with CRC.
引用
收藏
页码:313 / +
页数:10
相关论文
共 50 条
  • [41] TIME TO COLONOSCOPY ASSOCIATED WITH THE RISKS OF COLORECTAL CANCER AND ADVANCED COLORECTAL CANCER AFTER A POSITIVE RESULT OF FECAL IMMUNOCHEMICAL TESTING: RESULTS FROM A NATIONWIDE SCREENING PROGRAM
    Lee, Yi-Chia
    Chiang, Tsung-Hsien
    Hsu, Wen-Feng
    Chiu, Han-Mo
    Wu, Ming-Shiang
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S30 - S30
  • [42] Does the presence of symptoms increase the risk of colorectal cancer in patients with a positive fecal immunochemical test result?
    Hamarneh, Z.
    Symonds, E. L.
    Cock, C.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 162 - 162
  • [43] Prevalence of DNA Biomarkers in Fecal Immunochemical Test Positive and Negative Colorectal Cancers
    Levin, Theodore
    Doubeni, Chyke
    Jensen, Christopher
    Zhao, Wei
    Zebrowski, Alexis
    Oldham-Haltom, Rebecca
    Allawi, Hatim
    Lidgard, Graham
    Corley, Douglas
    Berger, Barry
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S614 - S615
  • [44] Risk Factors for a Positive Fecal Immunochemical Test in the Subsequent Screening for Colorectal Neoplasms
    Lee, Yi-Chia
    Chiu, Han-Mo
    Chiang, Tsung-Hsien
    Wang, Hsiu-Po
    Lin, Jaw-Town
    Wu, Ming-Shiang
    [J]. GASTROENTEROLOGY, 2013, 144 (05) : S203 - S203
  • [45] Prevalence of DNA Biomarkers in Fecal Immunochemical Test Positive and Negative Colorectal Cancers
    Levin, Theodore R.
    Doubeni, Chyke A.
    Jensen, Christopher D.
    Zhao, Wei K.
    Zebrowski, Alexis
    Oldham-Haltom, Rebecca
    Taylor, William R.
    Ahlquist, David A.
    Allawi, Hatim T.
    Lidgard, Graham P.
    Corley, Douglas A.
    Berger, Barry M.
    [J]. GASTROENTEROLOGY, 2015, 148 (04) : S207 - S208
  • [46] Colonoscopic Findings in Patients With Positive Fecal Immunochemical Test During a Pilot Study of Colorectal Cancer Screening in a Western Country: Partial Results
    Sorbello, Mauricio P.
    Ribeiro, Ulysses, Jr.
    Bastos Bastos, Victor Rossi
    Pfuetzenreiter, Vinicius
    Sousa, Afonso Henrique, Jr.
    Cohen, Diane
    Alves, Venancio Avancini
    Hashimoto, Claudio
    Nahas, Sergio
    Cecconello, Ivan
    Neto, Jose Eluf
    Safatle-Ribeiro, Adriana Vaz
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S116 - S116
  • [47] The Role of Fecal mRNA Cyclooxygenase 2 and Fecal Immunochemical Test to Detect Colorectal Cancer
    Saragih, Arlyando Hezron
    Abdullah, Murdani
    Yusra
    Handjari, Diah Rini
    Prabu, Oryza Gryagus
    [J]. ADVANCED SCIENCE LETTERS, 2017, 23 (07) : 6950 - 6953
  • [48] Quantitation of fecal Fusobacterium and fecal immunochemical test in detecting colorectal cancer and advanced neoplasia
    Wong, Sunny
    Kwong, Thomas
    Nakatsu, Geicho
    Wong, Martin
    Ng, Siew
    Wu, William
    Yu, Jun
    Sung, Joseph
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 8 - 8
  • [49] Evaluation of Combined use of Fecal Multigene Mutation Test and Fecal Immunochemical Test for Colorectal Cancer Screening
    Chen, Juan
    Lin, Jie
    Zhang, Lijing
    Chen, Mengshi
    Yu, Xunbin
    Wu, Yijuan
    Wang, Tao
    Xu, Rongrong
    Tian, Tian
    Sun, Aijuan
    Zhang, Tiantian
    Lu, Yan
    Ba, Zhaofen
    Cheng, Xiaowei
    Chen, Minghong
    [J]. CLINICAL LABORATORY, 2022, : 2446 - 2453
  • [50] Evaluation of Combined use of Fecal Multigene Mutation Test and Fecal Immunochemical Test for Colorectal Cancer Screening
    Chen, Juan
    Lin, Jie
    Zhang, Lijing
    Chen, Mengshi
    Yu, Xunbin
    Wu, Yijuan
    Wang, Tao
    Xu, Rongrong
    Tian, Tian
    Sun, Aijuan
    Zhang, Tiantian
    Lu, Yan
    Ba, Zhaofen
    Cheng, Xiaowei
    Chen, Minghong
    [J]. CLINICAL LABORATORY, 2022, 68 (12) : 2446 - 2453